Medical Pharmacology Chapter 43: Adult Cardiac Procedures
Chronic Drug Therapy, Previous Surgical, Diagnostic Procedures
Chronic Drug Treatment: major points
Do not discontinue ß-adrenoceptor perioperatively because discontinuation may cause:
Worsening angina (including infarction)
Hypertension
ß-adrenoceptor blocking drugs may be useful during anesthesia because these agents :
Reduce the likelihood of tachycardia
Have antiarrhythmic properties
Are antihypertensive
May reduce myocardial ischemia
Conclusions: ß-adrenoceptor blocking drugs
Except for long-acting agents ( e.g., nadolol (Corgard)), patient's usual morning does may be given orally along with preanesthetic medications {IV doses may be administered intraoperatively as needed to control heart rate/angina}
Calcium channel blockers:
Generally chronic administration is continued up to the morning of surgery
Antihypertensive drugs:
Generally these drugs are continued through the night before or the morning of surgery because:
They promote reduced perioperative hemodynamic stress
Of manageable interactions with anesthetic and cardiovascular drugs
Rebound hypertension may occur if antihypertensive drugs are abruptly discontinued (particular noted with clonidine (Catapres))
With angiotensin converting enzyme inhibitors (ACE inhibitors): continue these drugs until surgery and start them again as soon as possible postoperatively
Patients on ACE inhibitors probably have an attenuated blood pressure response to catecholamine infusions (increased doses may be required)
Drug Category |
Advantages |
Disadvantages |
Calcium Channel Antagonists |
|
|
ß-adrenoceptor blocking drugs |
|
|
Antihypertensive agents |
|
|
Diuretics |
|
|
Digitalis glycosides (digitoxin (Crystodigin); digitoxin (Crystodigin)) |
|
|
Antiarrhythmic agents |
|
|
Insulin |
|
|
Primary Reference: Ross, AF, Gomez, MN. and Tinker, JH Anesthesia for Adult Cardiac Procedures in Principles and Practice of Anesthesiology (Longnecker, D.E., Tinker, J.H. Morgan, Jr., G. E., eds) Mosby, St. Louis, Mo., pp. 1659-1698, 1998.
Primary Reference: Shanewise, JS and Hug, Jr., CC, Anesthesia for Adult Cardiac Surgery, in Anesthesia, 5th edition,vol 2, (Miller, R.D, editor; consulting editors, Cucchiara, RF, Miller, Jr.,ED, Reves, JG, Roizen, MF and Savarese, JJ) Churchill Livingston, a Division of Harcourt Brace and Company, Philadelphia, pp. 1753-1799, 2000.
Primary Reference: Wray Roth, DL, Rothstein, P and Thomas, SJ Anesthesia for Cardiac Surgery, in Clinical Anesthesia, third edition (Barash, PG, Cullen, BF, Stoelting, R.K, eds), Lippincott-Raven Publishers, Philadelphia, pp. 835-865, 1997
This Web-based pharmacology and disease-based integrated teaching site is based on reference materials, that are believed reliable and consistent with standards accepted at the time of development. Possibility of human error and on-going research and development in medical sciences do not allow assurance that the information contained herein is in every respect accurate or complete. Users should confirm the information contained herein with other sources. This site should only be considered as a teaching aid for undergraduate and graduate biomedical education and is intended only as a teaching site. Information contained here should not be used for patient management and should not be used as a substitute for consultation with practicing medical professionals. Users of this website should check the product information sheet included in the package of any drug they plan to administer to be certain that the information contained in this site is accurate and that changes have not been made in the recommended dose or in the contraindications for administration. Advertisements that appear on this site are not reviewed for content accuracy and it is the responsibility of users of this website to make individual assessments concerning this information. Medical or other information thus obtained should not be used as a substitute for consultation with practicing medical or scientific or other professionals. |